Fri.Aug 18, 2023

article thumbnail

ACS Fall 2023 First Disclosures  

Drug Hunter

The First Disclosures sessions at the 2023 ACS Fall Meeting in San Francisco, organized by Nikki Goodwin , presented a variety of new orally available small molecules. The standing room-only sessions were so highly attended that many attendees were unfortunately kicked out due to the fire code. In case you missed any of these exciting molecules, from Scorpion’s mutant-selective PI3Kα inhibitor to Nurix’s CNS-penetrant BTK degrader, here we share the structures and targets of all the novel molecu

article thumbnail

UK announces £210 million fund to tackle antimicrobial resistance

Drug Discovery World

The UK government has announced up to £210 ($267) million of funding to partner with countries across Asia and Africa to tackle antimicrobial resistance (AMR) and reduce the threat posed to the UK. The announcement follows the £39 ($48) million investment through the Global AMR Innovation Fund (GAMRIF) in May. The money is intended to pay for new laboratories, disease surveillance systems, and a bigger global workforce.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

WHO Monitoring Highly Mutated New Strain of COVID-19, Now Spotted in Michigan

Drugs.com

FRIDAY, Aug. 18, 2023 -- A new COVID variant with very few known cases but many mutations has been swiftly moved into the World Health Organization’s "variant under monitoring" classification. Four known cases of the variant, dubbed BA.2.86, have.

98
article thumbnail

This week in drug discovery (14-18 August)  

Drug Discovery World

News round-up for 14-18 August by DDW Digital Content Editor Diana Spencer. My chosen news stories this week all discuss pre-clinical research studies that could have a huge impact on our therapeutic approach to several hard-to-treat diseases, helping to overcome drug-resistance and make treatments more targeted in the future. Next-generation antivirals could target virus membranes Researchers have shown that a group of novel molecules inspired by our own immune system inactivates viruses like Z

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Blue Shield of California drops CVS Caremark in pharmacy benefit overhaul

BioPharma Drive: Drug Pricing

BSCA has kicked CVS Caremark, the largest pharmacy benefit manager in the country, to the curb and is electing to carve out various pharmacy functions with companies like Amazon instead.

article thumbnail

Thermo Fisher Scientific acquires real-world evidence provider

Drug Discovery World

Thermo Fisher Scientific has completed its acquisition of CorEvitas, a provider of real-world evidence for approved medical treatments and therapies, for $912.5 million. Real-world evidence is a high growth market segment as pharmaceutical and biotechnology customers, as well as regulating bodies, are increasingly looking to monitor and evaluate the safety of approved therapies and examine their effectiveness and value in the post approval setting.

More Trending

article thumbnail

FDA accelerates approval for multiple myeloma immunotherapy

Drug Discovery World

The US Food and Drug Administration (FDA) has granted accelerated approval to Pfizer’s Elrexfio (elranatamab-bcmm) for the treatment of adult patients with relapsed or refractory multiple myeloma (RRMM). The drug is approved in patients who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.

FDA 130
article thumbnail

Blinded by Chemical Burns, Patients Regained Sight With New Stem Cell Therapy

Drugs.com

FRIDAY, Aug. 18, 2023 -- Phillip Durst was working near an industrial dishwasher when something went awry, and the machinery spewed caustic chemicals into his eyes. “If I had been standing a foot left or right, it wouldn't have hit me right where.

article thumbnail

Specialty Treatments in the New Age of Affordability

Drug Channels

Today’s guest post is from Divya Iyer, Vice President of Strategy & Business Development, Pharma Manufacturer Solutions, at GoodRx. Divya discusses the challenges patients face in accessing specialty therapies prescribed by their healthcare providers. She suggests how the pharma industry can leverage GoodRx to help patients with access and affordability.

article thumbnail

Did Vlad the Impaler, Inspiration for Dracula, Shed Tears of Blood?

Drugs.com

FRIDAY, Aug. 18, 2023 – The 15th century prince who inspired the literary vampire Dracula may have had medical issues that caused him to cry tears of blood, according to researchers unearthing this ancient mystery. The prince, who was also a.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Innovative breakthrough in sustainable chemical production

SCIENMAG: Medicine & Health

Carbon capture and utilization (CCU) technologies are crucial for addressing climate change while ensuring economic viability. MES has emerged as a promising approach for CO2 reduction to biofuels and platform chemicals. However, the industrial adoption of MES has been hindered by low-value products like acetate or methane and high electric power demand.

article thumbnail

AHA News: 'I Feel Like I'm Dying': Days After Giving Birth, TV Anchor Couldn't Make Sense of Symptoms

Drugs.com

FRIDAY, Aug. 18, 2023 (American Heart Association News) -- Five days after giving birth to her second child, Lauren Lowrey woke up with a sharp pain in her upper back. She couldn't draw in a deep breath. The TV news anchor, who was living in.

98
article thumbnail

New LJI research has major implications for controlling T cell activity

SCIENMAG: Medicine & Health

LA JOLLA, CA—According to new research in the journal Immunity, T cells have a nuclear receptor doing something very odd—but very important—to help them fight pathogens and destroy cancer cells.

article thumbnail

Stem Cells Might Someday Create New Tooth Enamel or 'Living Fillings'

Drugs.com

FRIDAY, Aug. 18, 2023 -- Damaged teeth could one day be repaired with “living fillings” created from stem cells, a new study reports. In the lab, researchers induced stem cells to form small, multicellular mini-organs that secrete the.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

The 3Rs Principles in Cosmetic and Self-care Industry: the Regulation that Prioritises Animal Welfare

biobide

Cruelty-free cosmetics have emerged as a powerful statement within the beauty industry and Fast Moving Consumer Goods (FMCG), reflecting a growing consumer consciousness on the ethical treatment of animals. With an increased focus on animal welfare , the beauty industry has undergone a shift towards the 3Rs Principle application and all surrounding regulations.

article thumbnail

1 in 10 ICU Patients With Heart Issues Has Illicit Drugs in Their System

Drugs.com

FRIDAY, Aug. 18, 2023 -- More than 1 out of every 10 patients who land in an ICU with a potentially deadly heart emergency test positive for recreational drug use, a new French study reports. About 11% of nearly 1,500 patients admitted to a French.

Drugs 98
article thumbnail

Remote learning during pandemic aids medical students with disabilities

SCIENMAG: Medicine & Health

Medical students who reported a disability to their school increased by more than 25% during the COVID-19 pandemic, a study shows. The proportion of students reporting attention deficit hyperactivity disorder or chronic health and/or psychological disabilities has increased between 2015 and 2021.

92
article thumbnail

Viral Vectors 101: What is a Virus (and a Viral Vector)?

addgene Blog

Viruses are simple – a genome packaged in a protein shell (Taylor, 2014). They’re so simple that we can’t even decide if they’re alive or not. Yet these simple, small particles have quite the outsized impact – and not just on the disease front.

Virus 70
article thumbnail

Immunotherapy: Antibody kit to fight tumors

SCIENMAG: Medicine & Health

A new study highlights the potential of artificial DNA structures that, when fitted with antibodies, instruct the immune system to specifically target cancerous cells. Immunotherapy is viewed as an exceptionally promising weapon in the fight against cancer.

DNA 91
article thumbnail

Does Smoking Change the Teenage Brain?

Drugs.com

FRIDAY, Aug. 18, 2023 -- Teens’ desire to start smoking, and later to keep smoking, may be linked to differences in gray matter in their brains, a new study reveals. Researchers found that reduced gray matter in the left frontal lobe was found in.

article thumbnail

Researchers building green fertilizer system to reuse wastes, cut greenhouse gas emissions

SCIENMAG: Medicine & Health

AMES, Iowa – Midwest researchers want to take some of the greenhouse gas emissions out of crop fertilizer. Credit: Photo by Liang Dong/Iowa State University. AMES, Iowa – Midwest researchers want to take some of the greenhouse gas emissions out of crop fertilizer.

article thumbnail

Spear thrower weapon use by prehistoric females equalized the division of labor while hunting

Science Daily: Pharmacology News

A new study has demonstrated that the atlatl (i.e. spear thrower) functions as an 'equalizer', a finding which supports women's potential active role as prehistoric hunters.

75
article thumbnail

Auburn University hosts the 60th edition of the Renowned Computational Biophysics Workshop

SCIENMAG: Medicine & Health

AUBURN, AL – In July, as many enjoyed the hot weather at Alabama’s gulf coast beaches, in the Leach Science Center, Auburn University’s Department of Physics hosted an engaging scientific event.

Science 88
article thumbnail

No Evidence 'Blue Light-Filtering' Glasses Actually Help Eyes

Drugs.com

FRIDAY, Aug. 18, 2023 -- Heavy screen users often buy blue light-filtering eyeglasses to protect their eyes -- but they may be wasting their money, a new study suggests. A new research review suggests these blue light-filtering glasses probably make.

article thumbnail

Looking at the latest in Life Sciences Discovery and Technology

SCIENMAG: Medicine & Health

Oak Brook, IL – The August 2023 issue of SLAS Technology, the open access journal emphasizing scientific and technical advances across the life sciences, is now available. Volume 28, Issue 4, contains a review from the literature and eight full-length articles covering nanodiamonds, automated buffer exchange, epidermal growth factor (EGF) and other laboratory automation-related research.

Science 88
article thumbnail

Cell therapy that repairs cornea damage with patient's own stem cells achieves positive phase I trial results

Science Daily: Pharmacology News

Novel stem cell therapy called a CALEC transplant was performed safely in four patients with serious chemical burns tracked in a phase I clinical trial for 12 months. The patients experienced early clinical gains: two were able to undergo a corneal transplant and two reported significant improvements in vision without additional treatment. CALEC procedure takes small amount of stem cells from healthy eye, grows and expands stem cells on a graft, before it is transplanted into the patient's damag

article thumbnail

Illinois Tech engineer spearheads research leading to groundbreaking green propane production method

SCIENMAG: Medicine & Health

CHICAGO—August 18, 2023—A paper recently published in Nature Energy based on pioneering research done at Illinois Institute of Technology reveals a promising breakthrough in green energy: an electrolyzer device capable of converting carbon dioxide into propane in a manner that is both scalable and economically viable.

article thumbnail

Stimulants

Common Sense for Drug Policy Blog

Stimulants "Stimulants are a class of performance-enhancing substances some bodybuilders use to increase focus, alertness, and energy during their workouts. Some of the most commonly used stimulants in bodybuilding include amphetamines, caffeine, ephedrine, and clenbuterol. These substances are believed to enhance mental and physical performance, reduce fatigue, and improve endurance [ 25 ].

52
article thumbnail

DOE funds Gulf Coast-focused direct air capture hub feasibility study

SCIENMAG: Medicine & Health

The U.S. Department of Energy has awarded an LSU-led consortium a $4.9 million grant to support the first phase of the Pelican Gulf Coast Carbon Removal project. The Pelican Consortium, which includes Shell and the University of Houston, will evaluate the feasibility of building a direct air capture (DAC) hub in Louisiana.

87
article thumbnail

Analysis Life Sciences: A deep dive into MDR and IVDR implementation: Where we are and where we’re going

Agency IQ

A deep dive into MDR and IVDR implementation: Where we are and where we’re going Late last summer, AgencyIQ took a close look at how the European Commission had been meeting its goals in implementing the medical device and IVD regulations (MDR and IVDR, respectively). Today, we’re revisiting that deep dive to see what progress has been made since then.

article thumbnail

Nature-inspired pressure sensing technology that aims to transform healthcare and surgical robots

SCIENMAG: Medicine & Health

Researchers at the National University of Singapore (NUS) have developed a novel aero-elastic pressure sensor, called ‘eAir’. This technology can be applied to minimally-invasive surgeries and implantable sensors by directly addressing the challenges associated with existing pressure sensors.

article thumbnail

Article FDA: FDA’s informed consent guidance gets a 21st century makeover

Agency IQ

FDA’s informed consent guidance gets a 21st century makeover The FDA has issued a new, final guidance on informed consent for clinical investigations – the first update since 1998. The new guidance offers recommendations for institutional review boards (IRBs), investigators and sponsors on key aspects of informed consent, significantly expanding FDA’s recommendations on several key topics, including reimbursement for research participation.

FDA 52
article thumbnail

RESEARCH ALERT: City of Hope scientists unravel how TET2 gene deficiency fuels development of acute myeloid leukemia

SCIENMAG: Medicine & Health

FINDINGS Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States, have identified how low levels of the TET2 gene fuel the rapid growth of acute myeloid leukemia in animal models. Cell Stem Cell recently published the study.

article thumbnail

Article Periodic: EPA labs lack proper inspections, watchdog says

Agency IQ

EPA labs lack proper inspections, watchdog says The Environmental Protection Agency’s Office of Inspector General has published a new report finding that the agency has consistently failed to verify whether agency laboratories comply with hazardous waste requirements. The OIG and hazardous waste The Environmental Protection Agency’s (EPA) Office of Inspector General (OIG) is the agency’s independent investigation group.